Corporate ActionNov 2, 2026, 10:41 AM
AstraZeneca PLC Admits 11,948 Further Securities to Trading
AI Summary
AstraZeneca PLC has announced the admission of 11,948 additional ordinary shares to trading on the London Stock Exchange's Main Market. These shares were issued under the company's employee share schemes between October 1 and October 31, 2026, and were admitted under a pre-existing block admission from January 2021. Following this issuance, the total number of AstraZeneca ordinary shares in issue has reached 1,551,065,237, and the new shares are fully fungible with the existing ones.
Key Highlights
- AstraZeneca PLC admitted 11,948 further ordinary shares to trading on the London Stock Exchange's Main Market.
- These shares were issued between October 1, 2026, and October 31, 2026, under the company's employee share schemes.
- The admission was made under a block admission dated January 29, 2021.
- The total number of ordinary shares in issue following this admission is 1,551,065,237.
- The newly admitted shares are fully fungible with existing ordinary shares.
Price Impact
More from AZN